Business Standard

Sun Pharma, Divi's Lab, Piramal Enterprises: Time to bet on pharma stocks?

A bullish divergence on RSI favours the upside momentum along with MACD, which is in a positive crossover

index funds
Premium

Pharma Stocks

Avdhut Bagkar Mumbai
Nifty Pharma: The formation on the daily chart resembles 'Double Bottom'. A breakout may indeed lead to a sharp upside in the index, provided volume supports the move. That said, stability above 8,200 levels is crucial. A strong decline from 9,400 to 7,800 in just three months had disrupted the upside potential, so follow-up buying should play a crucial role in formalising an upward trend. CLICK HERE FOR DETAILED CHART VIEW
 
A bullish divergence on RSI (Relative Strength Index) also favours the upside momentum along with MACD (Moving Average Convergence Divergence), which is in

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in